Adaptimmune Therapeutics Plc's ability to collect accounts receivable sequentially worsen to 9.42, indicating more challenging environment then in the first quarter 2025, but still, it is a far cry from any concerns. Adaptimmune Therapeutics Plc's Accounts Receivable average collection period in the Jun 30 2025 quarter, has increased to 39 days, from 11 days, in the Mar 31 2025 quarter.

If we take a look into Healthcare sector 195 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2025 from 502 to 1741.

What is Receivable Turnover Ratio?
What is Adaptimmune Therapeutics Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADAP Receivables Turnover Ratio	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Receivable Change	298.84 %	-47.86 %	77.1 %	1484.28 %	-21.38 %
Y / Y Revenue Change	-89.33 %	28.3 %	1294.81 %	458.83 %	2399.63 %
Receivable Turnover Ratio (TTM)	9.42	34.76	28.84	29.1	45.82
ADAP's Total Ranking	# 1741	# 502	# 667	# 556	# 429
Accounts Receivable average collection period days	39	11	13	13	8
Seq. Receivable Change	112.53 %	201.38 %	-88.37 %	435.33 %	-72.22 %
Seq. Revenue Change	87.74 %	126.1 %	-92.12 %	-68.1 %	2158.38 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 24
Healthcare Sector	# 196
Overall Market	# 1741

Receivable Turnover Ratio Statistics
High	Average	Low
35.77	7.25	-1.5
(Jun 30 2024)		(Dec 31 2019)

ADAP Company Profile • Back to ADAP Efficiency Comparisons • Compare ADAP Receivables Turnover Ratio to its Competitors

Financial Statements
Adaptimmune Therapeutics Plc's Accounts Receivable	$ 9 Millions	Visit ADAP's Balance sheet
Adaptimmune Therapeutics Plc's Sales TTM	$ 65 Millions	Visit ADAP's Income Statement
Sources of ADAP's Revenues		Visit ADAP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADAP's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADAP's Growth Rates	ADAP's Roa	ADAP's Inventory Turnover Ratio	ADAP's Dividend Comparisons
ADAP's Profitability Ratios	ADAP's Roi	ADAP's Asset Turnover Ratio	ADAP's Dividend Growth
ADAP's Valuation Ratios	ADAP's Roe	ADAP's Financial Strength Ratios	ADAP's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2025	Receivable at quarter ending Jun 30 2025
Nurix Therapeutics Inc	18.61	$ 88.381 Millions	$ 4.750 Millions
Macrogenics Inc	18.32	$ 165.494 Millions	$ 9.034 Millions
Innovage Holding Corp	17.92	$ 853.699 Millions	$ 47.637 Millions
Clene Inc	17.88	$ 0.286 Millions	$ 0.016 Millions
Valion Bio Inc	17.77	$ 0.462 Millions	$ 0.026 Millions
Xoma Royalty Corporation	17.55	$ 44.952 Millions	$ 2.561 Millions
Vivos Therapeutics Inc	17.37	$ 14.050 Millions	$ 0.809 Millions
Talkspace Inc	16.84	$ 201.745 Millions	$ 11.979 Millions
Generation Bio Co	16.70	$ 21.230 Millions	$ 1.271 Millions
Scorpius Holdings inc	16.57	$ 2.409 Millions	$ 0.145 Millions
Petvivo Holdings Inc	16.51	$ 0.986 Millions	$ 0.060 Millions
Milestone Scientific Inc	15.95	$ 8.888 Millions	$ 0.557 Millions
Longeveron Inc	15.82	$ 2.073 Millions	$ 0.131 Millions
Siga Technologies Inc	15.31	$ 179.639 Millions	$ 11.732 Millions
Kiniksa Pharmaceuticals International Plc	15.28	$ 529.332 Millions	$ 34.647 Millions
Safe Pro Group Inc	14.98	$ 1.496 Millions	$ 0.100 Millions
Quipt Home Medical Corp	14.94	$ 422.961 Millions	$ 28.311 Millions
Ethema Health Corporation	14.53	$ 11.650 Millions	$ 0.802 Millions
Amneal Pharmaceuticals Inc	14.50	$ 2,851.220 Millions	$ 196.597 Millions
Inmed Pharmaceuticals Inc	14.32	$ 4.943 Millions	$ 0.345 Millions
Mannkind Corporation	14.03	$ 301.736 Millions	$ 21.508 Millions
Icu Medical Inc	13.41	$ 2,371.547 Millions	$ 176.808 Millions
China Pharma Holdings Inc	13.25	$ 4.396 Millions	$ 0.332 Millions
Sangamo Therapeutics Inc	13.24	$ 81.706 Millions	$ 6.170 Millions
Qhslab Inc	13.13	$ 2.421 Millions	$ 0.184 Millions
Protalix Biotherapeutics inc	12.89	$ 61.948 Millions	$ 4.805 Millions
Ptc Therapeutics inc	12.73	$ 1,764.929 Millions	$ 138.666 Millions
Cytokinetics Incorporated	12.55	$ 85.738 Millions	$ 6.829 Millions
Day One Biopharmaceuticals Inc	12.45	$ 187.638 Millions	$ 15.074 Millions
Rosecliff Acquisition Corp I	12.45	$ 28.320 Millions	$ 2.275 Millions

Date modified: 2026-06-23T20:00:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.